UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Molecular carcinogenesis, ISSN 0899-1987, 01/2019, Volume 58, Issue 1, pp. 156 - 160
BRIP1 | germline mutations | aberrant splicing | hereditary breast and ovarian cancer | Biochemistry & Molecular Biology | Oncology | Life Sciences & Biomedicine | Science & Technology | Genetic research | Breast cancer | Genetic aspects | Analysis | Genetic screening | Pathogens | Transcription | Splicing | Anemia | Fanconi syndrome | DNA repair | Pathogenicity | DNA helicase | Biological effects | Missense mutation | Mutation | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Journal of translational medicine, ISSN 1479-5876, 06/2020, Volume 18, Issue 1, pp. 1 - 232
Hereditary Cancer syndrome | Germline mutation | On-Demand gene panel | Genetic counselling | Next generation sequencing | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | BRCA2 protein | Phenotypes | MLH1 protein | Splicing | Laboratories | Colorectal carcinoma | MSH2 protein | Breast cancer | Ribonucleic acid--RNA | Genetic screening | Ovarian cancer | Sensory evaluation | Mutation | Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2020, Volume 71, Issue 2, pp. 658 - 669
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 02/2019, Volume 43, pp. 91 - 96
Hereditary Breast and Ovarian Cancer | Mutation screening | PALB2 | Germline mutations | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Carcinoma - drug therapy | Hereditary Breast and Ovarian Cancer Syndrome - genetics | Frameshift Mutation | Fanconi Anemia Complementation Group N Protein - genetics | Humans | Hereditary Breast and Ovarian Cancer Syndrome - drug therapy | Mutation, Missense | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Genetic Counseling | Case-Control Studies | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Spain | Ovarian Neoplasms - genetics | Breast Neoplasms - genetics | Pedigree | Age of Onset | Adult | Carcinoma - genetics | Female | Adenocarcinoma - genetics | Mutation | Ovarian Neoplasms - drug therapy | Care and treatment | Breast cancer | Ovarian cancer | Prevention | Proteins | Gene mutations | Analysis | Medical genetics | Genetic research | Genetic aspects | Diagnosis | Molecular biology | Health aspects | Cancer | Index Medicus
Journal Article
International journal of uncertainty, fuzziness, and knowledge-based systems, ISSN 0218-4885, 12/2016, Volume 24, pp. 63 - 85
Journal Article
Cancers, ISSN 2072-6694, 08/2020, Volume 12, Issue 8, pp. 1 - 17
Clinical guidelines | Genetic testing | Therapeutic selection | Variant prioritisation | Family history | HBOC | Life Sciences & Biomedicine | Oncology | Science & Technology | BRCA2 protein | Statistical analysis | BRCA1 protein | DNA damage | Genes | Genomes | Breast cancer | Family medical history | Cancer therapies | DNA repair | Ovarian cancer | Defects | Pathogenicity | Disease prevention | Proteins | Chemotherapy | Mutation | Diagnosis | Age | Deoxyribonucleic acid--DNA | Tumors | variant prioritisation | clinical guidelines | genetic testing | family history | therapeutic selection
Journal Article
British journal of haematology, ISSN 0007-1048, 09/2020, Volume 190, Issue 5, pp. e289 - e292
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Stroke - prevention & control | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Cardiovascular Diseases - mortality | Female | Aged | Glucagon-Like Peptides - therapeutic use | Immunoglobulin Fc Fragments - therapeutic use | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptides - analogs & derivatives | Diabetes Mellitus, Type 2 - complications | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Evidence-based medicine | Risk factors | Incidence | Randomization | Older people | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 131 - 138
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Albuminuria - prevention & control | Creatinine - urine | Glomerular Filtration Rate - drug effects | Female | Aged | Glucagon-Like Peptides - therapeutic use | Immunoglobulin Fc Fragments - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Glucagon-Like Peptides - analogs & derivatives | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Evidence-based medicine | Risk factors | Incidence | Randomization | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
European journal of cardio-thoracic surgery, ISSN 1010-7940, 2016, Volume 50, Issue 6, pp. 1149 - 1157
Endocarditis | Vascular grafting | Aorta | Thoracic | Propionibacterium acnes | Aorta, Thoracic | Staphylococcus aureus | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Surgery | Science & Technology | Vascular Grafting - methods | Endocarditis, Bacterial - etiology | Humans | Middle Aged | Vascular Grafting - adverse effects | Male | Blood Vessel Prosthesis | Endocarditis, Bacterial - epidemiology | Staphylococcal Infections - epidemiology | Blood Vessel Prosthesis Implantation - adverse effects | Aorta - surgery | Blood Vessel Prosthesis Implantation - methods | Endocarditis, Bacterial - microbiology | Female | Registries | Aged | Staphylococcal Infections - etiology | Index Medicus
Journal Article